In his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance alongside other leaders from Merck s businesses in India.
Merck, a leading science and technology company, demonstrated the robustness of its business model in financial year 2023 and achieved financial results in line with the forecast issued in August in a challenging market environment.
Merck confirmed its forecast for fiscal 2023 despite a difficult market environment in the third quarter. The strong organic development of the Healthcare business sector partly compensated for th .
Merck generated net sales of € 5.3 billion in the first quarter of 2023. This corresponds to an increase of 1.8% over the year-earlier quarter (organically 0.8%). Sales growth was in particular at .